Editorial
doi: 10.1002/cncr.30260.
Epub 2016 Aug 17.
Disparate clinical activity of PD-1 blockade in melanoma subtypes: Know thy enemy!
Affiliations
- PMID: 27533794
- DOI: 10.1002/cncr.30260
Item in Clipboard
Editorial
Disparate clinical activity of PD-1 blockade in melanoma subtypes: Know thy enemy!
Cancer.
.
Free article
Erratum in
-
Erratum.Cancer. 2017 Feb 15;123(4):710. doi: 10.1002/cncr.30492. Epub 2016 Dec 16. Cancer. 2017. PMID: 28165620 No abstract available.
No abstract available
Comment on
-
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies.Cancer. 2016 Nov 15;122(21):3344-3353. doi: 10.1002/cncr.30258. Epub 2016 Aug 17. Cancer. 2016. PMID: 27533448 Free PMC article.
-
The efficacy of anti-PD-1 agents in acral and mucosal melanoma.Cancer. 2016 Nov 15;122(21):3354-3362. doi: 10.1002/cncr.30259. Epub 2016 Aug 17. Cancer. 2016. PMID: 27533633 Free PMC article.
Similar articles
-
Interaction of human Thy-1 (CD 90) with the integrin alphavbeta3 (CD51/CD61): an important mechanism mediating melanoma cell adhesion to activated endothelium.Oncogene. 2005 Jul 7;24(29):4710-20. doi: 10.1038/sj.onc.1208559. Oncogene. 2005. PMID: 15897908
-
Melanoma cells use Thy-1 (CD90) on endothelial cells for metastasis formation.Am J Pathol. 2013 Jan;182(1):266-76. doi: 10.1016/j.ajpath.2012.10.003. Epub 2012 Nov 16. Am J Pathol. 2013. PMID: 23159525
-
Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs.Int Immunol. 2007 Oct;19(10):1223-34. doi: 10.1093/intimm/dxm091. Int Immunol. 2007. PMID: 17898045
-
Beyond melanoma: inhibiting the PD-1/PD-L1 pathway in solid tumors.Immunotherapy. 2016 May;8(5):583-600. doi: 10.2217/imt-2015-0029. Immunotherapy. 2016. PMID: 27140411 Review.
-
The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma.Clin Ther. 2015 Apr 1;37(4):764-82. doi: 10.1016/j.clinthera.2015.02.018. Epub 2015 Mar 29. Clin Ther. 2015. PMID: 25823918 Free PMC article. Review.
Cited by
-
Tumor-infiltrating lymphocyte composition, organization and PD-1/ PD-L1 expression are linked in breast cancer.Oncoimmunology. 2016 Dec 14;6(1):e1257452. doi: 10.1080/2162402X.2016.1257452. eCollection 2017. Oncoimmunology. 2016. PMID: 28197375 Free PMC article.
-
Concurrent treatment with transarterial immunoembolization of hepatic metastases and systemic immune checkpoint inhibitors to overcome immune evasion in patients with metastatic uveal melanoma.Cancer Immunol Immunother. 2025 Jul 15;74(8):270. doi: 10.1007/s00262-025-04124-x. Cancer Immunol Immunother. 2025. PMID: 40665019 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
